Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3930862 | 0.85 | ALDH1A1 (0.48) | ALDH1A1CYP3A4HPGDHSD17B10TSHR | |
| SCHEMBL21438669 | 0.82 | MEN1 (0.50) | ALDH1A1CYP3A4HPGDHSD17B10TSHR | |
| SCHEMBL25334951 | 0.80 | KMT2A (0.55) | ALDH1A1CYP3A4HPGDHSD17B10TSHR | |
| SCHEMBL325965 | 0.79 | MEN1 (0.51) | ALDH1A1CYP3A4HPGDHSD17B10TSHR | |
| Formaldehyde SCHEMBL29038646 | 0.75 | KMT2A (0.51) | ALDH1A1CYP3A4HPGDHSD17B10TSHR | |
| SCHEMBL29041190 | 0.75 | MEN1 (0.47) | ALDH1A1CYP3A4HPGDHSD17B10TSHR | |
| SCHEMBL1812608 | 0.74 | LTA4H (0.47) | KDM4ECYP2C9 | |
| SCHEMBL3625531 | 0.72 | ALDH1A1 (0.53) | ALDH1A1CYP3A4HPGDHSD17B10TSHR | |
| SCHEMBL308577 | 0.72 | KMT2A (0.56) | ALDH1A1CYP3A4HPGDHSD17B10TSHR | |
| SCHEMBL28172242 | 0.72 | KMT2A (0.49) | ALDH1A1HPGDHSD17B10TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220387633-A1 | SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-12-08 | — | — | US | disclosed |
| WO-2021030743-A2 | SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387633-A1 | SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY | ERBB2, FOLR2, EGFR | ALDH1A1 4685/4885CYP3A4 4768/4885HPGD 3855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.